Publications

ctive immunisation targeting nerve growth factor attenuates chronic pain behaviour in murine osteoarthritis

von Loga IS. et al, (2019), Annals of the Rheumatic Diseases, 78, 672 - 675

Fettelschoss‐Gabriel A. et al, (2019), Allergy, 74, 572 - 582

Engeroff P. and Bachmann MF., (2019), Expert Review of Vaccines, 18, 1 - 3

Bachmann MF. et al, (2019), Expert Opinion on Biological Therapy, 19, 73 - 78

Skibinski DAG. et al, (2018), Scientific Reports, 8

Klimek L. et al, (2018), Allergo Journal International, 27, 245 - 255

Zha L. et al, (2018), Journal of Allergy and Clinical Immunology, 142, 1529 - 1536.e6

Bachmann MF. et al, (2018), Frontiers in Microbiology, 9

Fettelschoss-Gabriel A. et al, (2018), Journal of Allergy and Clinical Immunology, 142, 1194 - 1205.e3

Cabral-Miranda G. et al, (2018), Biosensors and Bioelectronics, 113, 101 - 107

Engeroff P. et al, (2018), Journal of Allergy and Clinical Immunology, 142, 557 - 568.e6

Foerster J. and Bachmann M., (2018), Human Vaccines & Immunotherapeutics, 14, 1546 - 1547

Mohsen MO. et al, (2018), Vaccines, 6, 37 - 37

Bachmann MF. et al, (2018), Journal of Allergy and Clinical Immunology, 142, 279 - 281.e1

von Loga IS. et al, (2018), Osteoarthritis and Cartilage, 26, S355 - S355